Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivothrough suppression of PDGFR-β

Figure 3

Effects of imatinib mesylate on the proliferation of six MPNST cell lines. MPNST cells were incubated for 5 days with imatinib mesylate at the indicated concentrations in media containing 2% FCS. One to five μM of imatinib mesylate had significant inhibitory effects at day 5 in three cell lines, FU-SFT9817, HS-Sch-2, and FMS-1 cells. Data are the means ± SEM (n = 4). *P < 0.01, compared with the control group without imatinib mesylate (by Student’s t-test).

Back to article page